Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Buprenorphine Dosing for the Treatment of Opioid Use Disorder Through Pregnancy and Postpartum
Caitlin E. Martin, Caroline Shadowen, Bhushan Thakkar, et al.
Current Treatment Options in Psychiatry (2020) Vol. 7, Iss. 3, pp. 375-399
Open Access | Times Cited: 22

Showing 22 citing articles:

Gestational Opioid Exposure: From Morphine to MOUD – How Opioids Impact Offspring Development and Maternal Care
Jecenia Duran, Sadaf Khalid, Lauren Richardson, et al.
Current topics in behavioral neurosciences (2025)
Closed Access
The effects of buprenorphine and morphine during pregnancy: Impact of exposure length on maternal brain, behavior, and offspring neurodevelopment
Abigail M. Myers, Chela Wallin, Lauren M. Richardson, et al.
Neuropharmacology (2024) Vol. 257, pp. 110060-110060
Closed Access | Times Cited: 4
Addiction treatment in the postpartum period: an opportunity for evidence-based personalized medicine
Caitlin E. Martin, Anna Beth Parlier‐Ahmad
International Review of Psychiatry (2021) Vol. 33, Iss. 6, pp. 579-590
Open Access | Times Cited: 21
Perinatal morphine but not buprenorphine affects gestational and offspring neurobehavioral outcomes in mice
Brittany Smith, Ally Hassler, Kelsey Lloyd, et al.
NeuroToxicology (2023) Vol. 99, pp. 292-304
Open Access | Times Cited: 8
Fetal and Infant Effects of Maternal Opioid Use during Pregnancy: A Literature Review including Clinical, Toxicological, Pharmacogenomic, and Epigenetic Aspects for Forensic Evaluation
Elena Giovannini, Maria Paola Bonasoni, Jennifer P. Pascali, et al.
Children (2024) Vol. 11, Iss. 3, pp. 278-278
Open Access | Times Cited: 2
Access to Prenatal Care Among Patients With Opioid Use Disorder in Florida
Kimberly Fryer, Chinyere N. Reid, Amanda L. Elmore, et al.
Obstetrics and Gynecology (2023) Vol. 142, Iss. 5, pp. 1162-1168
Open Access | Times Cited: 6
Association Between Buprenorphine Dose and the Urine “Norbuprenorphine” to “Creatinine” Ratio: Revised
Hiroko Furo, Timothy J. Wiegand, Meenakshi Rani, et al.
Substance Abuse Research and Treatment (2023) Vol. 17
Open Access | Times Cited: 5
Maternal care behavior and physiology moderate offspring outcomes following gestational exposure to opioids
Abigail M. Myers, Scott E. Bowen, Susanne Brummelte
Developmental Psychobiology (2023) Vol. 65, Iss. 8
Closed Access | Times Cited: 5
Guideline No. 443b: Opioid Use Throughout Women’s Lifespan: Opioid Use in Pregnancy and Breastfeeding
Suzanne D. Turner, Victoria M. Allen, Glenda Carson, et al.
Journal of Obstetrics and Gynaecology Canada (2023) Vol. 45, Iss. 11, pp. 102144-102144
Closed Access | Times Cited: 5
Extended‐release buprenorphine in pregnancy
A A Hubbell, Ese Aghenta, Cresta Jones, et al.
American Journal on Addictions (2024) Vol. 33, Iss. 3, pp. 354-356
Open Access | Times Cited: 1
Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals
Jake R. Morgan, Ashley A. Leech
Addiction (2024) Vol. 119, Iss. 6, pp. 1123-1124
Open Access | Times Cited: 1
The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series
Caroline Shadowen, F. Gerard Moeller, Caitlin E. Martin
Journal of Addiction Medicine (2021) Vol. 15, Iss. 4, pp. 292-296
Open Access | Times Cited: 9
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Julia Tobacyk, Brian J. Parks, Paloma Salazar, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 110832-110832
Open Access | Times Cited: 2
Behandeling van opioïdverslaafde zwangere vrouwen met buprenorfine: invloed op de foetus en de pasgeborene
L. El-Bazioui, L. Terryn, Koenraad Smets
Tijdschrift voor Geneeskunde (2024)
Closed Access
Maternal buprenorphine split dosing
C Lopez Flores, Usman Riaz, Peter L. Tenore, et al.
Heroin addiction and related clinical problems (2024), pp. 1-8
Closed Access
A Pharmacologic Evaluation of Buprenorphine in Pregnancy and the Postpartum Period
Steve N. Caritis, Raman Venkataramanan
Journal of Addiction Medicine (2024)
Closed Access
An Approach for Improving the Detection and Quantitation of Buprenorphine and Its Metabolites in Maternal and Neonatal Hair
Osama Y. Alshogran, Wenchen Zhao, Elizabeth E. Krans, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
Andrea Nguyen, Hannah Shadowen, Caroline Shadowen, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
Anesthetic management of the parturient with opioid addiction
Laurence E. Ring, Ruth Landau
International Anesthesiology Clinics (2021) Vol. 59, Iss. 3, pp. 28-39
Closed Access | Times Cited: 1
Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
Amin Tavakoli, Kelly Donovan, Heather Sweeney, et al.
Cureus (2023)
Open Access
Treating Opioid Use During Pregnancy and Postpartum Life Phases
Hendrée E. Jones
Oxford University Press eBooks (2023), pp. 784-811
Closed Access
Directive clinique no 443b : Opioïdes aux différentes étapes de la vie des femmes : Grossesse et allaitement
Suzanne D. Turner, Victoria M. Allen, Glenda Carson, et al.
Journal of Obstetrics and Gynaecology Canada (2023) Vol. 45, Iss. 11, pp. 102146-102146
Closed Access
Page 1

Scroll to top